Results 211 to 220 of about 112,374 (313)

Angiotensin Receptor-Neprilysin Inhibition in Heart Failure With Reduced Ejection Fraction

, 2016
Marvin A. Konstam
openalex   +1 more source

IMPACT OF LEFT VENTRICULAR DIASTOLIC FUNCTION ON LONG-TERM MORTALITY IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION

, 2016
Jae-Yeong Cho, Kye Hun Kim, Youngkeun Ahn, Sang Eun Lee, Hyun‐Jai Cho, Hae‐Young Lee, Jin‐Oh Choi, Eun‐Seok Jeon, Min‐Seok Kim, Jae‐Joong Kim, Kyung‐Kuk Hwang, Shung Chul Chae, Sang Hong Baek, Seok‐Min Kang, Dong‐Ju Choi, Byung‐Su Yoo, Hyun‐Young Park, Myeong‐Chan Cho, Byung‐Hee Oh   +18 more
openalex   +1 more source

Left ventricular function improvement during angiotensin receptor–neprilysin inhibitor treatment in a cohort of HFrEF/HFmrEF patients

ESC Heart Failure, Volume 12, Issue 2, Page 1151-1165, April 2025.
Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller, Tobias Harm, Manuel Sigle, Parwez Aidery, Klaus‐Peter Kreisselmeier, Livia Baas, Andreas Goldschmied, Meinrad Paul Gawaz, Karin Anne Lydia Müller   +8 more
wiley   +1 more source

The effect of empagliflozin on cardiac function and structure in patients with heart failure with reduced ejection fraction: a systematic review and meta-analysis. [PDF]

Postepy Kardiol Interwencyjnej
Nan G, Yang CB, Jia ZK.
europepmc   +1 more source

New Biomarker in Heart Failure With Reduced Ejection Fraction

Circulation Journal, 2014
openaire   +4 more sources

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

ESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source

Using the 5Ms Framework to Advance Aging-Responsive Care for Heart Failure with Reduced Ejection Fraction. [PDF]

Clin Interv Aging
Latimer A, Moser DK, Wu JR, Birtcher KK, Clancy MJ, Portz JD, Paladino J, Matlock DD, Knoepke CE.   +8 more
europepmc   +1 more source

Implementation of guideline‐recommended medical therapy for patients with heart failure in Europe

ESC Heart Failure, Volume 12, Issue 2, Page 790-798, April 2025.
Abstract Physicians' adherence to guideline‐recommended heart failure (HF) treatment remains suboptimal, especially regarding the target doses. In particular, there is evidence that non‐cardiologists are less compliant with HF guideline recommendations. This is likely to have a detrimental impact on patients' survival, readmissions and quality of life.
Maurizio Volterrani, Petar Seferovic, Gianluigi Savarese, Ilaria Spoletini, Egidio Imbalzano, Antoni Bayes‐Genis, Ewa Jankowska, Michele Senni, Marco Metra, Ovidiu Chioncel, Andrew J. S. Coats, Giuseppe M. C. Rosano   +11 more
wiley   +1 more source

Cost-utility analysis of add-on Qili Qiangxin capsules in chronic heart failure with reduced ejection fraction in China. [PDF]

ESC Heart Fail
Wang L, Wang Y, Zhao Q.
europepmc   +1 more source